Biocardia Stock Target Price and Analyst Consensus

BCDA
 Stock
  

USD 1.49  0.03  2.05%   

The current analyst and expert consensus on Biocardia is Buy, with 0 strong sell and 2 strong buy opinions. The current projected Biocardia target price consensus is 10.33 with 3 analyst opinions. The most common way Biocardia analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Biocardia executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Biocardia. We encourage you to use your own analysis of Biocardia to validate this buy or sell advice. Biocardia buy-or-sell recommendation module provides average expert sentiment on the projected Biocardia target price to derive its highest and lowest estimates based on projected price volatility of 4.163. Continue to Macroaxis Advice on Biocardia to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
  
Refresh
The current year Gross Profit is expected to grow to about 1.1 M, whereas Profit Margin is forecasted to decline to (12.07) . Biocardia Total Assets are projected to increase significantly based on the last few years of reporting. The past year's Total Assets were at 15.72 Million. The current year Current Assets is expected to grow to about 14.6 M, whereas Cash and Equivalents is forecasted to decline to about 12 M.

Biocardia Target Price Consensus

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Biocardia target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Biocardia target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Number of Opinions3
Lowered Outlook0
Raized Outlook0
Buy
Most Biocardia analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Biocardia stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Biocardia, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Biocardia Target Price Projection

Biocardia's current and average target prices are 1.49 and 10.33, respectively. The current price of Biocardia is the price at which Biocardia is currently trading. On the other hand, Biocardia's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Biocardia Market Quote on 5th of July 2022

Low Price1.45Odds
High Price1.55Odds

1.49

Target Price

Analyst Consensus On Biocardia Target Price

Low Estimate7.0Odds
High Estimate15.0Odds
Number of Analysts3
Standard Deviation4.163

10.333

Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Biocardia and the information provided on this page.

Biocardia Analyst Ratings

Biocardia's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Biocardia stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Biocardia's financials, market performance, and future outlook by experienced professionals. Biocardia's historical ratings below, therefore, can serve as a valuable tool for investors.

Analyst Consensus Breakdown

Average Consensus Estimates

About Biocardia Target Price Projections

Biocardia's target price is an analyst's projection of its future price. Price targets can be assigned to all types of securities, from complex investment products to stocks such as Biocardia and even bonds. If the target price is unavailable, it is most likely because there were not enough analyst opinions to come up with a consensus estimate. When setting a price target estimate, an analyst is trying to determine what the Stock is worth and where the price will be in a year from now. Generally, the target price of Biocardia depends on its intrinsic valuation, beta (i.e., risk over market), and overall volatility. Most analysts publish their price targets in research reports on specific companies, along with their buy, hold, or sell recommendations. Stock price targets are often quoted in the financial news media. Macroaxis uses multiple feeds to provide overall target price projection for Biocardia including analysis of its current option contracts.
Biocardia's latest option contracts expiring on 2022-07-15 are carrying combined implied volatility of 921.41 with a put-to-call open interest ratio of 0.2 over 5 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2022-07-15. The current put volume is at 1, with calls trading at the volume of 0. This yields a 0.0 put-to-call volume ratio. The Biocardia option chain provides detailed quote and price information for the current Biocardia option contracts. It shows all of Biocardia's listed puts, calls, expiration dates, strike prices, and other pricing information.
Biocardia's stock options are financial instruments that give investors the right to buy or sell shares of Biocardia common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Biocardia stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Biocardia's stock price goes up or down, the stock options follow.
Continue to Macroaxis Advice on Biocardia to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.

Biocardia Current Options Market Mood

Biocardia's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Biocardia Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Most options investors, including buyers and sellers of Biocardia's calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Biocardia's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Biocardia's option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.

Additional Biocardia Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Biocardia is a key component of Biocardia valuation and have some predictive power on the future returns of a Biocardia.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Biocardia's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Biocardia in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
0.081.516.78
Details
Intrinsic
Valuation
LowReal ValueHigh
0.183.668.93
Details
Naive
Forecast
LowNext ValueHigh
0.0308411.546.81
Details
Earnings
Estimates (2)
LowProjected EPSHigh
-0.84-0.75-0.66
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Biocardia. Your research has to be compared to or analyzed against Biocardia's peers to derive any actionable benefits. When done correctly, Biocardia's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Biocardia.

Additional Biocardia Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Biocardia is a key component of Biocardia valuation and have some predictive power on the future returns of a Biocardia.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Biocardia's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Biocardia in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
0.081.516.78
Details
Intrinsic
Valuation
LowReal ValueHigh
0.183.668.93
Details
Naive
Forecast
LowNext ValueHigh
0.0308411.546.81
Details
Earnings
Estimates (2)
LowProjected EPSHigh
-0.84-0.75-0.66
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Biocardia. Your research has to be compared to or analyzed against Biocardia's peers to derive any actionable benefits. When done correctly, Biocardia's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Biocardia.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Macroaxis Index
Invested few shares
Cancer Fighters
Invested few shares
Continue to Macroaxis Advice on Biocardia to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. Note that the Biocardia information on this page should be used as a complementary analysis to other Biocardia's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Commodity Channel Index module to use Commodity Channel Index to analyze current equity momentum.

Complementary Tools for Biocardia Stock analysis

When running Biocardia price analysis, check to measure Biocardia's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biocardia is operating at the current time. Most of Biocardia's value examination focuses on studying past and present price action to predict the probability of Biocardia's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Biocardia's price. Additionally, you may evaluate how the addition of Biocardia to your portfolios can decrease your overall portfolio volatility.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
The data published in Biocardia's official financial statements usually reflect Biocardia's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Biocardia. For example, before you start analyzing numbers published by Biocardia accountants, it's critical to develop an understanding of what Biocardia's liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Biocardia's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Biocardia's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Biocardia's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Biocardia. Please utilize our Beneish M Score to check the likelihood of Biocardia's management to manipulate its earnings.